UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prevalence of Dietary Modification and Supplement Use in Patients with Metastatic Renal Cell Carcinoma Receiving Systemic Therapy

Nutrients, 2024-06, Vol.16 (11), p.1630

2024

Volltextzugriff (PDF)

Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results from a retrospective comparative analysis

World journal of urology, 2010-08, Vol.28 (4), p.543-547

2010

Volltextzugriff (PDF)

Sources of Frustration Among Patients Diagnosed With Renal Cell Carcinoma

Frontiers in oncology, 2019, Vol.9, p.11-11

2019

Volltextzugriff (PDF)

Distress in patients with renal cell carcinoma: a curious gap in knowledge

BJU international, 2019-02, Vol.123 (2), p.208-209

2019

Volltextzugriff (PDF)

Randomized Open-Label Phase II Trial of Apitolisib (GDC-0980), a Novel Inhibitor of the PI3K/Mammalian Target of Rapamycin Pathway, Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma

Journal of clinical oncology, 2016-05, Vol.34 (14), p.1660-1668

2016

Volltextzugriff (PDF)

COVID-19 and financial toxicity in patients with renal cell carcinoma

World journal of urology, 2021-07, Vol.39 (7), p.2559-2565

2021

Volltextzugriff (PDF)

IMmotion151: A Randomized Phase III Study of Atezolizumab Plus Bevacizumab vs Sunitinib in Untreated Metastatic Renal Cell Carcinoma (mRCC)

Journal of clinical oncology, 2018-02, Vol.36 (6_suppl), p.578-578

2018

Volltextzugriff (PDF)

Everolimus in metastatic renal cell carcinoma after failure of initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor (VEGFr-TKI) therapy: results of an interim analysis of a non-interventional study

Oncology research and treatment, 2013-03, Vol.36 (3), p.95-100

2013

Volltextzugriff (PDF)

MP51-13 ARTIFICIAL INTELLIGENCE HELPS IDENTIFY PROGNOSTIC PATTERNS IN RENAL CELL CARCINOMA SURGERY

The Journal of urology, 2024-05, Vol.211 (5S)

2024

Volltextzugriff (PDF)

Real world data on treatment of chromophobe renal cell carcinoma

Journal of clinical oncology, 2024-02, Vol.42 (4_suppl), p.409-409

2024

Volltextzugriff (PDF)

Comparison of financial toxicity among patients with non-metastatic versus metastatic renal cell carcinoma

Journal of clinical oncology, 2024-02, Vol.42 (4_suppl), p.408-408

2024

Volltextzugriff (PDF)

Patient priorities and expectations of systemic therapy in metastatic renal cell carcinoma

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.4560-4560

2023

Volltextzugriff (PDF)

Patient perceptions of benefits and risks of adjuvant therapy in renal cell carcinoma

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.663-663

2023

Volltextzugriff (PDF)

Financial toxicity in patients with metastatic renal cell carcinoma on combination therapy

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.651-651

2023

Volltextzugriff (PDF)

PD58-12 FINANCIAL TOXICITY IN NON-METASTATIC VERSUS METASTATIC RENAL CELL CARCINOMA PATIENTS

The Journal of urology, 2024-05, Vol.211 (5S)

2024

Volltextzugriff (PDF)

Patient perspectives on cytoreductive nephrectomy after CARMENA

Journal of clinical oncology, 2019-03, Vol.37 (7_suppl), p.658-658

2019

Volltextzugriff (PDF)

Patient perspectives on the impact of immune therapy on comorbid conditions in kidney cancer

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.640-640

2023

Volltextzugriff (PDF)

CASSIOPE: A prospective noninterventional study of cabozantinib treatment following prior vascular endothelial growth factor (VEGF) -targeted therapy in patients with advanced renal cell carcinoma (aRCC)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.4529-4529

2023

Volltextzugriff (PDF)

Patient-reported use of marijuana and cannabinoid (CBD) oil in patients with renal cell carcinoma undergoing systemic therapy

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.5084-5084

2020

Volltextzugriff (PDF)

Comparison of TKI and CPI strategies as first-line treatment of patients with advanced renal cell carcinoma: Real-world outcome data from the German research platform CARAT

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.4528-4528

2024

Volltextzugriff (PDF)

Subgroup analyses of efficacy outcomes by baseline tumor size in the phase 3, open-label CLEAR trial

Journal of clinical oncology, 2024-02, Vol.42 (4_suppl), p.364-364

2024

Volltextzugriff (PDF)

Comparison of efficacy and safety of checkpoint inhibitors in patients with genitourinary cancers aged below and above 75 years

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e16101-e16101

2019

Volltextzugriff (PDF)

Prevalence of dietary modification and supplement use in patients with metastatic renal cell carcinoma (mRCC)

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.662-662

2023

Volltextzugriff (PDF)

Heterogeneity of PD-L1 expression between primary and metastatic bladder cancer tumors and therapeutic implications between the immune cell score and combined positivity score

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e17041-e17041

2020

Volltextzugriff (PDF)

Patient preferences and expectations of systemic therapy in renal cell carcinoma

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.5083-5083

2020

Volltextzugriff (PDF)

1 – 25 von 84

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(84)
Mit Volltextzugriff
(67)

Publikationsform

Artikel
(84)

Sprache

Englisch
(84)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(30)
Life Sciences & Biomedicine
(29)
Humans
(21)
Female
(17)
Male
(17)
Middle Aged
(14)
Renal Cell Carcinoma
(14)
Oncology
(13)
Aged
(12)
Urology & Nephrology
(11)
Kidney Cancer
(10)
Adult
(7)
Carcinoma, Renal Cell - Pathology
(7)
Carcinoma, Renal Cell - Surgery
(7)
Kidney Neoplasms - Pathology
(7)
Carcinoma, Renal Cell - Drug Therapy
(6)
Medicin Och Hälsovetenskap
(6)
Metastases
(6)
Metastasis
(6)
Patients
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Prevalence of Dietary Modification and Supplement Use in Patients with Metastatic Renal Cell Carcinoma Receiving Systemic Therapy

Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results from a retrospective comparative analysis

Sources of Frustration Among Patients Diagnosed With Renal Cell Carcinoma

Distress in patients with renal cell carcinoma: a curious gap in knowledge

Randomized Open-Label Phase II Trial of Apitolisib (GDC-0980), a Novel Inhibitor of the PI3K/Mammalian Target of Rapamycin Pathway, Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma

COVID-19 and financial toxicity in patients with renal cell carcinoma

IMmotion151: A Randomized Phase III Study of Atezolizumab Plus Bevacizumab vs Sunitinib in Untreated Metastatic Renal Cell Carcinoma (mRCC)

Everolimus in metastatic renal cell carcinoma after failure of initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor (VEGFr-TKI) therapy: results of an interim analysis of a non-interventional study

MP51-13 ARTIFICIAL INTELLIGENCE HELPS IDENTIFY PROGNOSTIC PATTERNS IN RENAL CELL CARCINOMA SURGERY

Real world data on treatment of chromophobe renal cell carcinoma

Comparison of financial toxicity among patients with non-metastatic versus metastatic renal cell carcinoma

Patient priorities and expectations of systemic therapy in metastatic renal cell carcinoma

Patient perceptions of benefits and risks of adjuvant therapy in renal cell carcinoma

Financial toxicity in patients with metastatic renal cell carcinoma on combination therapy

PD58-12 FINANCIAL TOXICITY IN NON-METASTATIC VERSUS METASTATIC RENAL CELL CARCINOMA PATIENTS

Patient perspectives on cytoreductive nephrectomy after CARMENA

Patient perspectives on the impact of immune therapy on comorbid conditions in kidney cancer

CASSIOPE: A prospective noninterventional study of cabozantinib treatment following prior vascular endothelial growth factor (VEGF) -targeted therapy in patients with advanced renal cell carcinoma (aRCC)

Patient-reported use of marijuana and cannabinoid (CBD) oil in patients with renal cell carcinoma undergoing systemic therapy

Comparison of TKI and CPI strategies as first-line treatment of patients with advanced renal cell carcinoma: Real-world outcome data from the German research platform CARAT

Subgroup analyses of efficacy outcomes by baseline tumor size in the phase 3, open-label CLEAR trial

Comparison of efficacy and safety of checkpoint inhibitors in patients with genitourinary cancers aged below and above 75 years

Prevalence of dietary modification and supplement use in patients with metastatic renal cell carcinoma (mRCC)

Heterogeneity of PD-L1 expression between primary and metastatic bladder cancer tumors and therapeutic implications between the immune cell score and combined positivity score

Patient preferences and expectations of systemic therapy in renal cell carcinoma

Suchergebnisse filtern